Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;5(4):e000769.
doi: 10.1136/esmoopen-2020-000769.

Hormonal control of cancer: an outdated topic?

Maximilian Marhold  1
Affiliations
Editorial

Hormonal control of cancer: an outdated topic?

Maximilian Marhold. ESMO Open. 2020 Aug.
No abstract available

Keywords: cancer; endocrine therapy; hormone.

PubMed Disclaimer

Conflict of interest statement

Competing interests: MM has received honoraria for lectures and consultation from Roche, Lilly, Novartis and Medmedia and travel support from Amgen, Roche, Novartis, Pierre Fabre, Daiichi Sankyo and Eisai.

References

    1. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Trans Med Chir Soc Edinb 1896;15:153–79. - PMC - PubMed
    1. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22:232–40. 10.3322/canjclin.22.4.232 - DOI - PubMed
    1. Miller AB. An overview of hormone-associated cancers. Cancer Res 1978;38:3985–90. - PubMed
    1. James ND, de Bono JS, Spears MR, et al. . Abiraterone for prostate cancer not previously treated with hormone therapy. N Engl J Med 2017;377:338–51. 10.1056/NEJMoa1702900 - DOI - PMC - PubMed
    1. Burki TK. Enzalutamide in castration-resistant prostate cancer. Lancet Oncol 2014;15:e312. 10.1016/S1470-2045(14)70251-7 - DOI - PubMed

Publication types

Substances